| Foreword | p. 7 |
| Definitions, health claims and new challenges | |
| Definition and analysis of dietary fibre in the context of food carbohydrates | p. 21 |
| Abstract | p. 21 |
| Introduction | p. 21 |
| Dietary fibre analysis | p. 22 |
| New definitions of dietary fibre | p. 23 |
| Concluding remarks | p. 24 |
| References | p. 25 |
| Health claims, options for dietary fibre | p. 27 |
| Abstract | p. 27 |
| Introduction | p. 27 |
| What are the developments in food and health? | p. 28 |
| What do these developments mean for dietary fibre? | p. 35 |
| What kinds of claims for dietary fibre are substantiated by scientific evidence? | p. 36 |
| Conclusions | p. 37 |
| References | p. 37 |
| Whole grain health claims in the United States, United Kingdom and Sweden | p. 39 |
| Abstract | p. 39 |
| Introduction | p. 40 |
| US wholegrain health claim | p. 42 |
| UK Wholegrain health claim | p. 45 |
| Swedish wholegrain health claim | p. 49 |
| Wholegrain health claims: Implications | p. 52 |
| Dietary fibres - New challenges for research | p. 59 |
| Abstract | p. 59 |
| Introduction | p. 59 |
| Functional food development | p. 60 |
| The challenge of dietary fibre | p. 60 |
| Structure-function relationships | p. 61 |
| Target populations | p. 61 |
| Mode of action within the colon | p. 62 |
| Synbiotics | p. 63 |
| Nutrigenomics | p. 63 |
| Applications of dietary fibre | p. 63 |
| The definition of dietary fibre | p. 64 |
| Regulatory and safety aspects | p. 64 |
| Dietary fibre and the consumer | p. 65 |
| Acknowledgements | p. 65 |
| References | p. 66 |
| Analytical tools, technological aspects and applications | |
| Rapid bio-analytical methods - New developments | p. 69 |
| Abstract | p. 69 |
| Introduction | p. 69 |
| Fructans and Fructo-oligosaccharides | p. 73 |
| Cyclodextrins | p. 76 |
| Native and partially hydrolysed galactomannan and glucomannan | p. 77 |
| Conclusions | p. 79 |
| References | p. 80 |
| Analytical characterization of carbohydrates: From polymer through oligomer to monomer | p. 83 |
| Abstract | p. 83 |
| Introduction | p. 83 |
| Characterization of polysaccharides | p. 84 |
| NSP oligosaccharides | p. 87 |
| Improvement of precision and accuracy in the inulin - FOS determination in food products by using HPAEC-PAD | p. 89 |
| Discussion | p. 92 |
| Summarizing conclusions | p. 96 |
| References | p. 97 |
| Advanced in vitro models of the gastro-intestinal tract - Novel tools to study functionality of dietary fibres | p. 99 |
| Abstract | p. 99 |
| TNO's in vitro models of the gastro-intestinal tract | p. 99 |
| Viscosity and gastric emptying | p. 102 |
| Viscosity and glycaemic response | p. 103 |
| Degree of digestibility and fermentability of dietary fibre, and the energy value of fibres | p. 105 |
| Effects of the composition and activity of the large intestinal microbiota on colonic health | p. 106 |
| Binding of cholesterol and fat by dietary fibres | p. 108 |
| Conclusions | p. 109 |
| Acknowledgements | p. 109 |
| References | p. 109 |
| The importance of food structure on the glycaemic responses of carbohydrate rich foods | p. 113 |
| Abstract | p. 113 |
| Obesity, diabetes and carbohydrates | p. 113 |
| Does food microstructure affect GI response? | p. 115 |
| Fibre additions to Carbohydrate foods | p. 118 |
| Conclusion | p. 121 |
| References | p. 124 |
| Dietary fibres: their uses in dairy based applications | p. 127 |
| Abstract | p. 127 |
| Characteristics of dietary fibres | p. 127 |
| Dietary fibres in dairy products | p. 128 |
| Conclusion | p. 132 |
| References | p. 132 |
| Importance of phytosterols, folates and other bioactive compounds in cereals | p. 135 |
| Abstract | p. 135 |
| Introduction | p. 135 |
| Phytosterols | p. 135 |
| Folates | p. 137 |
| Conclusions | p. 139 |
| References | p. 139 |
| Health benefits of dietary fibre | |
| Dietary fibre intake, disease prevention, and health promotion: An overview with emphasis on evidence from epidemiology | p. 143 |
| Abstract | p. 143 |
| Introduction | p. 143 |
| Intakes of fibre around the world | p. 144 |
| Fibre recommendations around the world | p. 144 |
| Fibre intakes | p. 144 |
| Fibre intakes in countries of Europe | p. 145 |
| Fibre intakes in Eastern Europe | p. 148 |
| Fibre intakes in Southern Europe and the Mediterranean | p. 149 |
| Fibre intakes in the Pacific Rim | p. 149 |
| Dietary fibre intake in Africa and Latin America | p. 150 |
| Dietary fibre intake USA | p. 150 |
| Dietary fibre intake summary | p. 151 |
| Dietary fibre and all cause mortality | p. 151 |
| Dietary fibre and obesity | p. 152 |
| Dietary fibre and diabetes and the metabolic syndrome | p. 152 |
| Dietary fibre and coronary heart disease | p. 153 |
| Dietary fibre and colon health | p. 154 |
| Dietary fibre and other cancers of the gastrointestinal tract | p. 156 |
| Dietary fibre and breast and other hormonal cancers | p. 158 |
| Summary | p. 158 |
| References | p. 159 |
| Experimental studies of dietary fibre and colon cancer- an overview | p. 165 |
| Abstract | p. 165 |
| Introduction | p. 166 |
| Human studies | p. 167 |
| Animal studies | p. 168 |
| Mechanisms | p. 170 |
| Some significant dietary fibre sources | p. 171 |
| Fibre associated phytochemicals | p. 173 |
| Energy dense fibre deplete diet | p. 174 |
| Conclusions | p. 174 |
| Acknowledgements | p. 175 |
| References | p. 175 |
| Epidemiology of dietary fibre and colorectal cancer | p. 179 |
| Abstract | p. 179 |
| References | p. 180 |
| Dietary fibre, lipid metabolism and cardiovascular disease | p. 183 |
| Abstract | p. 183 |
| Introduction | p. 183 |
| Dietary fibre and dietary lipid intake | p. 184 |
| Dietary fibre and fat digestion | p. 185 |
| Dietary fibre and lipid absorption | p. 186 |
| Dietary fibre and lipid or sterol ileal excretion | p. 187 |
| Dietary fibre and postprandial metabolism | p. 187 |
| Dietary fibre and cardiovascular risk factors | p. 188 |
| Dietary fibre and cardiovascular risk | p. 189 |
| Conclusion | p. 190 |
| References | p. 191 |
| Intestinal flora and health | p. 197 |
| Abstract | p. 197 |
| Introduction | p. 198 |
| General idea of probiotics | p. 198 |
| Sub-optimal health state | p. 200 |
| References | p. 201 |
| Health benefits of specific types of dietary fibre | |
| Cholesterol-lowering activity of insoluble fibre from carob | p. 205 |
| Abstract | p. 205 |
| Introduction | p. 205 |
| Animal trials on cholesterol-lowering activity of carob fibre | p. 208 |
| Human intervention trials on cholesterol-lowering activity of carob fibre | p. 209 |
| Conclusions | p. 215 |
| Acknowledgements | p. 215 |
| References | p. 216 |
| Effects of resistant maltodextrin on metabolism of glucose and lipids | p. 219 |
| Abstract | p. 219 |
| Introduction | p. 219 |
| Developmental process | p. 220 |
| Physicochemical characteristics | p. 221 |
| Effects on glucose metabolism | p. 222 |
| Effects on lipid metabolism | p. 226 |
| Conclusion | p. 229 |
| References | p. 229 |
| Effect of extra-cellular polysaccharides on satiety | p. 231 |
| Abstract | p. 231 |
| Introduction | p. 231 |
| References | p. 235 |
| The effect of various inulins and Clostridium difficile on the metabolic activity and composition of the human colonic microbiota in vitro | p. 237 |
| Abstract | p. 237 |
| Introduction | p. 238 |
| Materials | p. 240 |
| Analytical methods | p. 243 |
| Results | p. 245 |
| Discussion | p. 249 |
| Acknowledgements | p. 251 |
| References | p. 251 |
| The role of prebiotic fibres in the process of calcium absorption | p. 255 |
| Abstract | p. 255 |
| Introduction | p. 255 |
| Dietary fibre | p. 256 |
| The prebiotic effect | p. 257 |
| Mineral absorption | p. 259 |
| Conclusion | p. 262 |
| References | p. 263 |
| Health aspects for target groups | |
| The effect of inulin/fructo-oligosaccharide as a prebiotic ingredient in baby formulae | p. 267 |
| Abstract | p. 267 |
| Introduction | p. 267 |
| Methods | p. 268 |
| Results | p. 269 |
| Conclusion | p. 270 |
| References | p. 270 |
| The role of fibre in clinical nutrition | p. 271 |
| Abstract | p. 271 |
| Introduction | p. 271 |
| Guidelines for fibre level and type in clinical nutritional products | p. 272 |
| Physiological effects of dietary fibre | p. 274 |
| Clinical applications for fibre-containing products | p. 277 |
| Normalization of bowel function | p. 278 |
| Constipation | p. 281 |
| Diarrhoea | p. 282 |
| Fibre-containing nutritional products for paediatrics | p. 285 |
| Contraindications and risks for use of fibre-containing products | p. 286 |
| Additional health benefits from fibres | p. 289 |
| Summary | p. 289 |
| References | p. 290 |
| The role of dietary fibre in companion animal nutrition | p. 295 |
| Abstract | p. 295 |
| Introduction | p. 296 |
| Fermentative capacity of companion animals | p. 297 |
| Effects of dietary fibre on food intake and gastric and small intestinal function in companion animals | p. 298 |
| Effects of dietary fibre on large intestinal function in companion animals | p. 305 |
| Clinical significance of dietary fibre in companion animals | p. 314 |
| Strategies for incorporating dietary fibre into companion animal diets | p. 318 |
| Summary and conclusions | p. 320 |
| References | p. 320 |
| Xylo-oligosaccharides alter metabolism of gut microbes and blood xylose levels in chicks | p. 329 |
| Abstract | p. 329 |
| Introduction | p. 329 |
| Materials and methods | p. 330 |
| Results and Discussions | p. 330 |
| Conclusions | p. 332 |
| References | p. 332 |
| The dietary fibre 2003 conference: An overview | |
| The dietary fibre 2003 conference: An overview | p. 335 |
| Abstract | p. 335 |
| Definition, structure, and analytical tools | p. 335 |
| Health benefits of dietary fibre | p. 337 |
| Health considerations for target groups: infants, patients, farm animals, and companion animals | p. 340 |
| Exploring and underpinning options for health-promoting products | p. 341 |
| Conclusions, recommendations and future perspectives | p. 343 |
| Index | p. 347 |
| Table of Contents provided by Rittenhouse. All Rights Reserved. |